Bandari Jathin 4
4 · Protara Therapeutics, Inc. · Filed Jan 23, 2024
Insider Transaction Report
Form 4
Bandari Jathin
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-01-19$1.91/sh−2,879$5,499→ 56,704 total - Award
Common Stock
2024-01-19+23,000→ 59,583 total - Award
Stock Option (Right to Buy)
2024-01-19+137,000→ 137,000 totalExercise: $1.91Exp: 2034-01-18→ Common Stock (137,000 underlying)
Footnotes (3)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one-third installments on the first, second and third anniversaries of January 19, 2024.
- [F2]25% of the shares vest on the one year anniversary of January 19, 2024 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
- [F3]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2023.